| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-SUSD1-1:1 | CACAUCUAGAUCCAUACUUUUUGGGCUCAACUCAGGGUUACCAAAAUAG… | 4488 nt | 0.4276 |
| lnc-SUSD1-1:2 | UUUGUGUGUGGUUUUGUAACAUGAUUCUUUCAGUCAUCAUUUCCAGGCC… | 3030 nt | 0.4488 |
| lnc-SUSD1-1:3 | UAUGUUUUGUAAACAAUUUUUCGAGUUCAUAAUUUUUCAAUCUUGUUUG… | 599 nt | 0.3957 |
| lnc-SUSD1-1:4 | UACUGAUCUAUUUCUGUGCCAAUACCACCUACUGUAACUUUAAAAUAGG… | 2917 nt | 0.4765 |
| lnc-SUSD1-1:5 | CAUGCACAUCUAGAUCCAUACUUUUUGGGCUCAACUCAGGGUUACCAAA… | 5478 nt | 0.4266 |
| lnc-SUSD1-1:6 | CAUGCACAUCUAGAUCCAUACUUUUUGGGCUCAACUCAGGGUUACCAAA… | 4492 nt | 0.4276 |
No relevant information is available at the moment.
A study in humans identified a long noncoding RNA, the lnc-SUSD1-1, as a potential biomarker for myocardial infarction occurrence, as referenced in the scientific literature [Liu et al. DOI:10.1111/jcmm.14163].